178 related articles for article (PubMed ID: 4032285)
1. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
Woodworth JR; Owens SM; Mayersohn M
J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
[TBL] [Abstract][Full Text] [Related]
2. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
Woodworth JR; Mayersohn M; Owens SM
J Pharmacol Exp Ther; 1986 Sep; 238(3):900-4. PubMed ID: 3746667
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine disposition in humans after small doses of radiolabeled drug.
Cook CE; Perez-Reyes M; Jeffcoat AR; Brine DR
Fed Proc; 1983 Jun; 42(9):2566-9. PubMed ID: 6852275
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs.
Owens SM; Mayersohn M
Drug Metab Dispos; 1986; 14(1):52-8. PubMed ID: 2868866
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
6. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats.
McClurkan MB; Valentine JL; Arnold L; Owens SM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148
[TBL] [Abstract][Full Text] [Related]
7. Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.
Valentine JL; Arnold LW; Owens SM
J Pharmacol Exp Ther; 1994 Jun; 269(3):1079-85. PubMed ID: 8014850
[TBL] [Abstract][Full Text] [Related]
8. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
9. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
11. Long-term disposition of phencyclidine in mice.
Martin BR
Drug Metab Dispos; 1982; 10(2):189-93. PubMed ID: 6124408
[TBL] [Abstract][Full Text] [Related]
12. Phencyclidine disposition after intravenous and oral doses.
Cook CE; Brine DR; Jeffcoat AR; Hill JM; Wall ME; Perez-Reyes M; Di Guiseppi SR
Clin Pharmacol Ther; 1982 May; 31(5):625-34. PubMed ID: 7075111
[TBL] [Abstract][Full Text] [Related]
13. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
Zorbas M; Owens SM; Plunkett LM; Bui H
Drug Metab Dispos; 1989; 17(6):641-5. PubMed ID: 2575500
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of N-nitrosodimethylamine in beagles.
Gombar CT; Pylypiw HM; Harrington GW
Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two and three compartment models of phencyclidine in man.
Domino SE; Domino LE; Domino EF
Subst Alcohol Actions Misuse; 1982; 3(4):205-11. PubMed ID: 7167862
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
